Lack of association between matrix metalloproteinase-9 gene-1562C/T polymorphism and preeclampsia: a meta-analysis

被引：8

作者：

Gong, Li-Li ^{[1
]}

Liu, He ^{[1
]}

Liu, Li-Hong ^{[1
]}

机构：

[1] Beijing Capital Med Univ, Beijing Chao Yang Hosp, Beijing, Peoples R China

来源：

HYPERTENSION IN PREGNANCY | 2014年 / 33卷 / 04期

基金：

中国国家自然科学基金;

关键词：

Matrix metalloproteinases; Meta analysis; Preeclampsia; Polymorphism; MATRIX METALLOPROTEINASES; HYPERTENSIVE DISORDERS; MMP-9; GENE;

D O I：

10.3109/10641955.2014.915033

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Studies investigating the association between matrix metalloproteinases (MMPs) gene polymorphisms and preeclampsia (PE) reported contradictory or non-conclusive results. We performed a meta-analysis of five studies that examined the relationship between PE and the MMP9-1562C>T polymorphism. The PubMed, Embase, and Google Scholar databases were searched to access the relevant genetic association studies up to September 2013. The meta-analysis revealed that there was no evidence for significant association between MMP9-1562C>T polymorphism and risk of PE. Large, multiethnic confirmatory, and well-designed studies are needed to further explore the relation between preeclampsia and polymorphisms of the MMPs gene.

引用

页码：389 / 394

页数：6

共 20 条

[11]

Moher D, 2009, ANN INTERN MED, V151, P264, DOI [10.7326/0003-4819-151-4-200908180-00135, 10.1136/bmj.b2700, 10.1371/journal.pmed.1000097, 10.1136/bmj.i4086, 10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]

[12] Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [J].

Palei, A. C. T. ;

Sandrim, V. C. ;

Amaral, L. M. ;

Machado, J. S. R. ;

Cavalli, R. C. ;

Lacchini, R. ;

Duarte, G. ;

Tanus-Santos, J. E. .

PHARMACOGENOMICS JOURNAL, 2012, 12 (06) :489-498

[13]

Palei ACT, 2013, CURR DRUG TARGETS, V14, P325

[14] Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy [J].

Palei, Ana C. T. ;

Sandrim, Valeria C. ;

Amaral, Lorena M. ;

Machado, Jackeline S. R. ;

Cavalli, Ricardo C. ;

Duarte, Geraldo ;

Tanus-Santos, Jose E. .

EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2012, 92 (02) :217-221

[15] Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension [J].

Palei, Ana C. T. ;

Sandrim, Valeria C. ;

Duarte, Geraldo ;

Cavalli, Ricardo C. ;

Gerlach, Raquel F. ;

Tanus-Santos, Jose E. .

CLINICA CHIMICA ACTA, 2010, 411 (11-12) :874-877

[16]

Rahimi Z, 2013, BIOMARK MED, V7, P93, DOI [10.2217/BMM.12.95, 10.2217/bmm.12.95]

[17]

Ros HS, 2000, AM J MED GENET, V91, P256

[18] Meta-analysis of observational studies in epidemiology - A proposal for reporting [J].

Stroup, DF ;

Berlin, JA ;

Morton, SC ;

Olkin, I ;

Williamson, GD ;

Rennie, D ;

Moher, D ;

Becker, BJ ;

Sipe, TA ;

Thacker, SB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (15) :2008-2012

[19] Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry [J].

Visse, R ;

Nagase, H .

CIRCULATION RESEARCH, 2003, 92 (08) :827-839

[20] Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis [J].

Zhang, BP ;

Ye, S ;

Herrmann, SM ;

Eriksson, P ;

de Maat, M ;

Evans, A ;

Arveiler, D ;

Luc, G ;

Cambien, F ;

Hamsten, A ;

Watkins, H ;

Henney, AM .

CIRCULATION, 1999, 99 (14) :1788-1794

← 1 2 →